From: A retrospective study of cases diagnosed with cystic fibrosis at a single care center in Syria
Number of patients | The pathogenic variant on the first allele | The first pathogenic variant class | The pathogenic variant on the second allele | The second pathogenic variant class | Sweat chloride values (mmol/l) | Age at diagnosis (months) |
---|---|---|---|---|---|---|
14 | W1282X | I | W1282X | I | 58±42 | 5.3±3.8 |
1 | W1282X | I | R1162X | I | 60 | 3 |
1 | R1162X | I | R1162X | I | 120 | 2.5 |
1 | 2183AA>G | I | 2183AA>G | I | 50 | 30 |
1 | 394delTT | I | 394delTT | I | 57 | 83 |
1 | G542X | I | G542X | I | 60 | 42 |
1 | W1282X | I | F508del | II | 65 | 4 |
1 | 2183AA>G | I | N1303K | II | 61 | 7 |
3 | CFTRdel2-3 | I | G551D | III | 84±8 | 4±1 |
1 | W1282X | I | R334W | IV | 96 | 2 |
2 | CFTRdel2-3 | I | R347P | IV | 28±5 | 7±6 |
1 | CFTRdel2-3 | I | R334W | IV | 89 | 6 |
1 | CFTRdel2-3 | I | 3849+10Kb C>T | V | 25 | 11 |
5 | 3199 del 6/I148T | II/polymorphism | 3199 del 6/I148T | II/polymorphism | 61±26 | 7±5 |
31 | F508del | II | F508del | II | 58±25 | 19±35 |
1 | F508del | II | N1303K | II | 60 | 3 |
4 | G85E | II | G85E | II | 47±15 | 4±1 |
6 | N1303K | II | N1303K | II | 70±23 | 30±47 |
1 | R334W | IV | R347P | IV | 35 | 1 |
4 | R347P | IV | R347P | IV | 53±29 | 2.5±1 |
3 | 1898+1G>A | V | 1898+1G>A | V | 68±39 | 9±2.5 |
1 | R334W | IV | 1898+1G>A | V | 100 | 100 |
2 | CFTRdel2-3 | I | - | - | 33±00 | 5.5±0.3 |
1 | N1303K | II | - | - | 60 | 3 |
1 | R1162X | I | - | - | 55 | 95 |
2 | F508del | II | - | - | 45±2 | 10±12 |
1 | 2789+5G >A | V | - | - | 85 | 3 |
1 | 2184delA | I | - | - | 35 | 1 |
2 | R334W | IV | - | - | 18.5 | 34±37 |
3 | G85E | II | - | - | 50 | 2.8±0.3 |